1. EMA expands recall of contaminated valsartan products

   News item 25 August 2018 Pages: 1 - 1

2. Immune-mediated encephalitis cases with Zinbryta

   Correspondence 25 August 2018 Pages: 2 - 2

3. Medsafe introduces new paediatric restrictions for codeine

   News item 25 August 2018 Pages: 3 - 3

4. New contraindication for Esmya in UK and Ireland

   Correspondence 25 August 2018 Pages: 4 - 4

5. New measures to reinforce restrictions for HES solutions

   Correspondence 25 August 2018 Pages: 5 - 5

6. New recommendations to avoid medication, testing errors

   News item 25 August 2018 Pages: 6 - 6

7. Renal crisis risk with oral glucocorticoids for sclerosis

   News item 25 August 2018 Pages: 7 - 7

8. TGA releases 2017 statistics for PV of medicines, vaccines

   Unknown 25 August 2018 Pages: 8 - 8

9. Methods, findings of Cochrane review on HPV vaccines criticised

   Comment 25 August 2018 Pages: 9 - 9

10. Antihypertensive FDCs increase risk of therapeutic duplication

    Clinical study 25 August 2018 Pages: 10 - 10

11. Efavirenz: incidence of CNS and psychiatric disorders in Uganda

    Clinical study 25 August 2018 Pages: 11 - 11

12. Iclaprim reduces risk of acute kidney injury, saves costs

    Clinical study 25 August 2018 Pages: 12 - 12

13. Increased risk of ventricular arrhythmias with ibrutinib

    Clinical study 25 August 2018 Pages: 13 - 13

14. Abciximab

    Case report 25 August 2018 Pages: 14 - 14

15. Acenocoumarol

    Case report 25 August 2018 Pages: 15 - 15

16. Aciclovir

    Case report 25 August 2018 Pages: 16 - 16

17. Adalimumab

    Case report 25 August 2018 Pages: 17 - 17

18. Adalimumab

    Case report 25 August 2018 Pages: 18 - 18

19. Adalimumab

    Case report 25 August 2018 Pages: 19 - 19

20. Adalimumab

    Case report 25 August 2018 Pages: 20 - 20

21. Adalimumab

    Case report 25 August 2018 Pages: 21 - 21

22. Adalimumab

    Case report 25 August 2018 Pages: 22 - 22

23. Alcohol

    Case report 25 August 2018 Pages: 23 - 23

24. Alemtuzumab

    Case report 25 August 2018 Pages: 24 - 24

25. Alendronic-acid

    Case report 25 August 2018 Pages: 25 - 25

26. Allopurinol/cefoxitin

    Case report 25 August 2018 Pages: 26 - 26

27. Allopurinol/rivaroxaban

    Case report 25 August 2018 Pages: 27 - 27

28. Alprazolam withdrawal

    Case report 25 August 2018 Pages: 28 - 28

29. Alteplase/dalteparin sodium

    Case report 25 August 2018 Pages: 29 - 29

30. Amantadine

    Case report 25 August 2018 Pages: 30 - 30

31. Amantadine/levodopa

    Case report 25 August 2018 Pages: 31 - 31

32. Amiodarone

    Case report 25 August 2018 Pages: 32 - 32

33. Amiodarone/metoprolol

    Case report 25 August 2018 Pages: 33 - 33

34. Amlodipine

    Case report 25 August 2018 Pages: 34 - 34

35. Amphotericin-B

    Case report 25 August 2018 Pages: 35 - 35

36. Amphotericin-B-liposomal/immunosuppressants

    Case report 25 August 2018 Pages: 36 - 36

37. Anaesthetics

    Case report 25 August 2018 Pages: 37 - 37

38. Anastrozole

    Case report 25 August 2018 Pages: 38 - 38

39. Antibacterials

    Case report 25 August 2018 Pages: 39 - 39

40. Antibacterials/NSAIDs

    Case report 25 August 2018 Pages: 40 - 40

41. Anticoagulants/antiplatelets

    Case report 25 August 2018 Pages: 41 - 41

42. Antineoplastics

    Case report 25 August 2018 Pages: 42 - 42

43. Antineoplastics

    Case report 25 August 2018 Pages: 43 - 43

44. Antineoplastics

    Case report 25 August 2018 Pages: 44 - 44

45. Antineoplastics

    Case report 25 August 2018 Pages: 45 - 45

46. Antineoplastics

    Case report 25 August 2018 Pages: 46 - 46

47. Antineoplastics

    Case report 25 August 2018 Pages: 47 - 47

48. Antineoplastics

    Case report 25 August 2018 Pages: 48 - 48

49. Antiparkinsonians/tramadol

    Case report 25 August 2018 Pages: 49 - 49

50. Antiretrovirals

    Case report 25 August 2018 Pages: 50 - 50